Cabaletta Bio, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Cabaletta Bio, Inc. reported Cash And Cash Equivalents At Carrying Value of $82.98 million for the year ending 2025.

  • Cabaletta Bio, Inc. showed a decrease of -49.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Cabaletta Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), Cabaletta Bio, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 151.3%.
  • Historical annual values: Fiscal year 2025: $82.98 million | Fiscal year 2024: $163.96 million | Fiscal year 2023: $193.24 million | Fiscal year 2022: $81.61 million | Fiscal year 2021: $122.22 million | Fiscal year 2020: $101.43 million | Fiscal year 2019: $136.20 million | Fiscal year 2018: $33.02 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: